Project Grant R01DA062257
Award Date
9/30/24
Completion Date
7/31/29
Dollars Obligated
$708K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Stony Brook, NY 11794, USA
Similar Awards
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,429,566 to the University of California, San Diego (UCSD) to conduct a comprehensive investigation on the individual and combined impact of HIV and opioids on inflammasome-mediated neuroinflammation and neurotoxicity. The research aims to uncover the mechanistic intersection between HIV and opioids that heightens inflammation, offering...
The National Institute on Drug Abuse (NIDA) awarded a $777,398 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Boston University Medical Campus to investigate the mechanisms of persistent inflammasome activation in myeloid cells related to HIV infection and opioid use disorder. The research, led by the principal investigator at Boston University, will utilize primary human iPSC-derived microglia cultures to examine how HIV infection and opioid exposure impact...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $234,000.00 to Georgetown University to study the effects of opioids on HIV transcription and latency. The research aims to understand how opioids influence the progression of HIV in the central nervous system, including the mechanisms by which opioids may reactivate latent HIV reservoirs in the brain. The project utilizes a novel dual...
This $2,103,564 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to investigate the cellular mechanisms and therapeutic potential of the nuclear receptor NR4A1 in pain resolution. The grant will fund research to test whether NR4A1 in macrophages controls the resolution of inflammation and postoperative pain, whether NR4A1 agonists can promote pain resolution, and whether NR4A1...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,411,610 in funding to the University of Nebraska Medical Center (UNMC) to investigate the combined effects of HIV Tat protein and opioids on glial-neuronal interactions, with a focus on the role of extracellular microRNAs. The research aims to elucidate how HIV and opioid co-morbidity exacerbates synaptic injury and dysfunction, and to...
This $751,043 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research investigating the cellular and molecular mechanisms underlying the complex co-occurrence of opioid use disorder (OUD), major depressive disorder (MDD), and HIV in the human brain. The award will fund a comprehensive study using advanced multi-omics approaches, including single-nucleus RNA sequencing and single-nucleus ATAC...
This Project Grant award of $3,717,777 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Icahn School of Medicine at Mount Sinai (ISMMS). The grant aims to investigate the impact of nicotine exposure on NLRP3 inflammasome activation in the central nervous system of individuals with HIV-1 and substance use disorders. The research will utilize human tonsil explants, iPSC-derived microglia, and a humanized mouse model...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $173,799 to support a 2-year research project at the University of Pennsylvania focused on understanding the role of the brain's endogenous opioid system in pain and placebo analgesia. The project aims to investigate the signaling dynamics and function of enkephalinergic neural populations in the ventrolateral periaqueductal gray (VLPAG) and the...
This $4,801,857 federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to compare the effects of different medications for opioid use disorder (MOUD) on neuroinflammation and neurocognition in people living with HIV (PLWH). The goal is to evaluate whether opioid antagonist MOUD (e.g., XR-naltrexone) have anti-inflammatory and neuroprotective effects compared to opioid agonist MOUD...
This $601,612 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research to investigate the role of the habenula-interpeduncular nucleus (IPN) circuit in the development of opioid tolerance and withdrawal. The project will use viral approaches, ribosome profiling, and calcium imaging in mice to examine gene expression changes and neuronal activity in the IPN in response to chronic oxycodone exposure. The...